THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
批准号:
8458137
负责人:
Sheila A Stewart
金额:
$23.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-17 至 2015-04-30
关键词:
Actinic keratosisAgeAgingAging-Related ProcessAtypical Ductal Breast HyperplasiaBenignBreastCancer EtiologyCell AgingCell ProliferationCellsClear CellComplexCoupledDataDevelopmentEnvironmentEpithelialFibroblastsFunctional disorderGene MutationGoalsGrowthHumanIn VitroIncidenceInterventionInvestigationLeadLesionMAP Kinase GeneMalignant NeoplasmsMediatingMedicalMembraneMicroarray AnalysisMolecularMusMutationNeoplasmsNormal CellPapillomaPathway interactionsPhenotypePlayPopulationProcessProtocols documentationRNA InterferenceRecombinantsRisk FactorsRoleSignaling MoleculeStagingStromal CellsTissuesTranscriptTumorigenicityXenograft Modelage relatedagedbasecancer cellcell growthdimethylbenzanthracenehuman tissuein vivoneoplastic cellnon-geneticosteopontinprogramsreceptorreceptor bindingsenescenceskin lesiontumortumor growthtumor progressiontumorigenesistumorigenic
中文摘要
SAtBatSeTmReAntCoTf假设和具体目标
年龄是肿瘤发生的最大危险因素。关于年龄如何影响的调查
癌症发病率的增加主要集中在早期癌症中自主突变的积累。
细胞。虽然这些细胞自主变化显然是转换过程中不可或缺的,但它已经
很明显,在这个过程中,周围表面上正常的间质的变化会协同作用,并可能
导致癌症发病率随年龄的增加而增加。事实上,肿瘤内的“正常”成纤维细胞
分泌促进肿瘤细胞生长的因子。就像基因突变一样,衰老的成纤维细胞会随着
年龄,最近的数据表明,它们在肿瘤的发生中起着关键作用。我们假设
衰老的成纤维细胞在间质间隔内增加,它们创造了促肿瘤形成
支持癌前细胞生长和持续转化的环境。要确定
支持癌前细胞生长的衰老成纤维细胞衍生因子,我们进行了一项无偏见的研究
比较年轻和衰老成纤维细胞的微阵列分析。我们发现骨桥蛋白(OPN)是一种
假定基质因子能够促进癌前细胞的增殖,因此假设它发挥了作用
在肿瘤发生中起着重要作用。为了支持这一假设,我们发现OPN在
人体皮肤和乳房良性病变的间质间质。而OPN的表达已经
与肿瘤进展相关(33,34),间质来源的OPN在早期病变中所起的作用尚未见报道
被调查过了。这项建议的目标是确定OPN的分子机制
影响转换过程的早期阶段。为此,这项建议的具体目标是:
目的1.鉴定成纤维细胞来源的骨桥蛋白与膜结合的受体复合体
受体结合时激活的近端信号分子
目的2.确定成纤维细胞来源的骨桥蛋白如何刺激癌前细胞的增殖
目的3.确定OPN的表达如何在衰老激活时进行调节
目的4.确定成纤维细胞来源的骨桥蛋白在肿瘤发生中的作用
英文摘要
SAtBatSeTmReAntCoTf Hypothesis and Specific Aims
Age is the single largest risk factor for the development of neoplasia. Investigation into how age contributes to
increased cancer incidence has focused on accumulation of autonomous mutations within incipient cancer
cells. While it is clear that these cell autonomous changes are integral to the transformation process, it has
become evident that changes in the surrounding, ostensibly normal stroma collaborate in the process and may
contribute to the age-dependent increase in cancer incidence. Indeed, "normal" fibroblasts within a tumor
secrete factors that promote tumor cell growth. Like genetic mutations, senescent fibroblasts accumulate with
age, and recent data suggests that they play a pivotal role in tumorigenicity. We hypothesize that as
senescent fibroblasts increase within the stromal compartment they create a pro-tumorigenic
environment that supports the growth and continued transformation of preneoplastic cells. To identify
senescent fibroblast-derived factors that support preneoplastic cell growth, we carried out a nonbiased
microarray analysis comparing young and senescent fibroblasts. We identified osteopontin (OPN) as a
putative stromal factor capable of enhancing preneoplastic cell proliferation and thus hypothesize that it plays
an important role in tumorigenesis. In support of this hypothesis, we found that OPN is expressed within the
stromal compartment of benign human lesions of the skin and breast. While OPN expression has been
correlated with tumor progression (33, 34), the role that stromal-derived OPN plays in early lesions has not
been investigated. The goal of this proposal is to determine the molecular mechanisms by which OPN
influences the early stages of the transformation process. To that end, the specific aims of this proposal are:
Aim 1. Identify the receptor complex(es) engaged by fibroblast-derived OPN and the membrane
proximal signaling molecules activated upon receptor binding
Aim 2. Determine how fibroblast-derived OPN stimulates preneoplastic cell proliferation
Aim 3. Determine how OPN expression is regulated upon activation of senescence
Aim 4. Determine the impact of fibroblast-derived OPN on tumorigenesis
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1158/1541-7786.mcr-10-0472
发表时间:
2011-08
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
[Luo X, Ruhland MK, Pazolli E, Lind AC, Stewart SA]
通讯作者:
Stewart SA
DOI:
10.1615/critrevoncog.2014010630
发表时间:
2013
期刊:
Critical reviews in oncogenesis
影响因子:
--
作者:
[Alspach E, Fu Y, Stewart SA]
通讯作者:
Stewart SA
DOI:
10.21769/bioprotoc.1481
发表时间:
2015-05
期刊:
Bio-protocol
影响因子:
0.8
作者:
[Elise Alspach;S. Stewart]
通讯作者:
Elise Alspach;S. Stewart
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY
-
批准号:9897506
-
项目类别:
-
资助金额:$50.39万
-
财政年份:2018
-
负责人:Sheila A Stewart
-
依托单位:
MICROENVIRONMENTAL CONTROLS OF TUMOR DORMANCY
-
批准号:10376279
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2018
-
负责人:Sheila A Stewart
-
依托单位:
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS
-
批准号:10057360
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2017
-
负责人:Sheila A Stewart
-
依托单位:
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS
-
批准号:10310473
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2017
-
负责人:Sheila A Stewart
-
依托单位:
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation
-
批准号:8658021
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation
-
批准号:8835061
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation
-
批准号:8286861
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation
-
批准号:8461250
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
Uncovering the Mechanisms by which Aged Stroma Impacts Tumor Initiation
-
批准号:8184104
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY
-
批准号:8678946
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY
-
批准号:8333934
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY
-
批准号:8500390
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
TELOMERE BINDING PROTEINS AND CELLULAR AGING
-
批准号:8361372
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
HDNA2 IN DNA REPLICATION AND TELOMERE STABILITY
-
批准号:8186317
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2011
-
负责人:Sheila A Stewart
-
依托单位:
TELOMERE BINDING PROTEINS AND CELLULAR AGING
-
批准号:8168727
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2010
-
负责人:Sheila A Stewart
-
依托单位:
TELOMERE BINDING PROTEINS AND CELLULAR AGING
-
批准号:7953959
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2009
-
负责人:Sheila A Stewart
-
依托单位:
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
-
批准号:8059601
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2009
-
负责人:Sheila A Stewart
-
依托单位:
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
-
批准号:7872927
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2009
-
负责人:Sheila A Stewart
-
依托单位:
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
-
批准号:8249141
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2009
-
负责人:Sheila A Stewart
-
依托单位:
THE ROLE OF FIBROBLAST-DERIVED OSTEOPONTIN IN TUMORIGENESIS
-
批准号:7731815
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2009
-
负责人:Sheila A Stewart
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: